Editas Medicine, Inc. financial data

Symbol
EDIT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
11 Hurley St., Cambridge, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 595 % -25.6%
Debt-to-equity 41.5 % +21.5%
Return On Equity -47.3 % +15.8%
Return On Assets -33.5 % +20.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 82.2M shares +19.2%
Common Stock, Shares, Outstanding 82.2M shares +19.2%
Entity Public Float 671M USD +5.89%
Common Stock, Value, Issued 8K USD +14.3%
Weighted Average Number of Shares Outstanding, Basic 81.9M shares +18.9%
Weighted Average Number of Shares Outstanding, Diluted 81.9M shares +18.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 69.4M USD +205%
Research and Development Expense 189M USD +7.92%
General and Administrative Expense 66M USD -11%
Operating Income (Loss) -185M USD +18.1%
Nonoperating Income (Expense) 19.1M USD +165%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -166M USD +24.1%
Earnings Per Share, Basic -2.07 USD/shares +34.9%
Earnings Per Share, Diluted -2.07 USD/shares +34.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 69.2M USD -46.3%
Marketable Securities, Current 227M USD +19.8%
Assets, Current 306M USD -5.83%
Property, Plant and Equipment, Net 13.3M USD +0.35%
Operating Lease, Right-of-Use Asset 31.4M USD -13.5%
Other Assets, Noncurrent 9.49M USD +40.5%
Assets 440M USD -5.12%
Accounts Payable, Current 7.97M USD -11.9%
Employee-related Liabilities, Current 8.65M USD +45.2%
Accrued Liabilities, Current 31.5M USD -0.25%
Contract with Customer, Liability, Current 14.7M USD +78.6%
Liabilities, Current 66.5M USD +16.3%
Contract with Customer, Liability, Noncurrent 54.2M USD -10.7%
Operating Lease, Liability, Noncurrent 21.8M USD -24.4%
Other Liabilities, Noncurrent 3.47M USD
Liabilities 146M USD -0.47%
Accumulated Other Comprehensive Income (Loss), Net of Tax -326K USD +85.7%
Retained Earnings (Accumulated Deficit) -1.29B USD -14.7%
Stockholders' Equity Attributable to Parent 294M USD -7.27%
Liabilities and Equity 440M USD -5.12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -49.9M USD -39.4%
Net Cash Provided by (Used in) Financing Activities 118M USD +9093%
Net Cash Provided by (Used in) Investing Activities -4.75M USD -120%
Common Stock, Shares Authorized 195M shares 0%
Common Stock, Shares, Issued 82.2M shares +19.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -54.4M USD -335%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 73.1M USD -45%
Deferred Tax Assets, Valuation Allowance 329M USD +11%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 338M USD +9.45%
Operating Lease, Liability 36.5M USD -16.9%
Depreciation 1.41M USD -8.74%
Payments to Acquire Property, Plant, and Equipment 1.87M USD +1.69%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -164M USD +24.9%
Lessee, Operating Lease, Liability, to be Paid 43.4M USD -19.6%
Property, Plant and Equipment, Gross 40.8M USD +16.1%
Operating Lease, Liability, Current 12.4M USD +48.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.39M USD -32.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.8M USD +2.02%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.91M USD -31.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.13M USD +0.08%
Deferred Tax Assets, Operating Loss Carryforwards 153M USD +5.88%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 13.7M USD +15.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.08M USD +2.11%
Operating Lease, Payments 3.85M USD -1.28%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 9.19M USD -26.8%
Share-based Payment Arrangement, Expense 22.9M USD +2.26%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%